Franklin Resources
ACRS icon

Franklin Resources’s Aclaris Therapeutics ACRS Stock Holding History

Franklin Resources’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-41,994
Closed -$611K – 2433
2021
Q4 		$611K Buy
41,994
+5,394
+15% +$81.7K ﹤0.01% 1837
2021
Q3 		$659K Buy
+36,600
New +$587K ﹤0.01% 1783
2019
Q3 		– Sell
-3,845,423
Closed -$8.42M – 1508
2019
Q2 		$8.42M Sell
3,845,423
-159,391
-4% -$869K ﹤0.01% 934
2019
Q1 		$24M Buy
4,004,814
+18,392
+0.5% +$122K 0.01% 701
2018
Q4 		$29.5M Buy
3,986,422
+1,088,112
+38% +$11.2M 0.02% 610
2018
Q3 		$42.1M Sell
2,898,310
-72,155
-2% -$1.24M 0.02% 585
2018
Q2 		$59.3M Buy
2,970,465
+395,074
+15% +$7.3M 0.03% 491
2018
Q1 		$45.1M Sell
2,575,391
-21,423
-0.8% -$454K 0.02% 565
2017
Q4 		$64M Buy
2,596,814
+565,945
+28% +$13.8M 0.03% 476
2017
Q3 		$52.4M Buy
2,030,869
+75,488
+4% +$2.02M 0.03% 515
2017
Q2 		$53M Buy
1,955,381
+697,104
+55% +$19M 0.03% 516
2017
Q1 		$37.5M Sell
1,258,277
-269,272
-18% -$7.76M 0.02% 611
2016
Q4 		$41.5M Sell
1,527,549
-39,964
-3% -$1.02M 0.02% 573
2016
Q3 		$40.1M Sell
1,567,513
-7,371
-0.5% -$156K 0.02% 593
2016
Q2 		$29.1M Sell
1,574,884
-64,570
-4% -$1.28M 0.02% 692
2016
Q1 		$31.1M Sell
1,639,454
-15,440
-0.9% -$295K 0.02% 682
2015
Q4 		$44.6M Buy
+1,654,894
New +$32.2M 0.02% 582

Other funds holding ACRS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Franklin Resources's ACRS Position: Q1 2022 in Review

Franklin Resources sold out of Aclaris Therapeutics (ACRS) in Q1 2022, closing a stake of 41,994 shares — an estimated $611K sold.

Franklin Resources first reported a position in ACRS in Q4 2015 and held it in 17 quarters. The position peaked at $64M in Q4 2017. 109 funds tracked by Wall St. Rank hold ACRS as of Q1 2022.

  • Franklin Resources reported no remaining Aclaris Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Franklin Resources sold 41,994 Aclaris Therapeutics shares in Q1 2022, an estimated $611K.
  • Franklin Resources first reported a position in Aclaris Therapeutics in Q4 2015 and held it in 17 quarters.
  • Franklin Resources's Aclaris Therapeutics position peaked at $64M in Q4 2017.
  • 109 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q1 2022.

Based on Franklin Resources's 13F filing for Q1 2022, filed 13 May 2022.